News | September 21, 2008

GE Healthcare Demos Cardiac Heart Failure Imaging Tool

September 22, 2008 - GE Healthcare demonstrated a new diagnostic tool for heart failure called SyncTool by Syntermed on its GE Xeleris 2 workstations at the American Society of Nuclear Cardiology, Sept. 10-14, in Boston.

SyncTool software is designed to help to predict which heart failure patients will benefit from cardiac resynchronization therapy (CRT). SyncTool uses multiharmonic phase analysis (MHPA), a technology developed by Emory University medical scientists Ernest Garcia, Ph.D., and Ji Chen, Ph.D., and was licensed exclusively to Syntermed by Emory in June 2008. The software provides an automated analysis of LV function of conventional ECG-gated SPECT myocardial perfusion imaging.

Emory University announced it is exclusively licensing Emory Reconstruction Toolbox (ERTb) to Syntermed and the company will market ERTb software as ReconTools. ReconTools provide reconstructed data sets that can be analyzed by many quantitative platforms including Emory Cardiac Toolbox (ECTb), providing an integrated, complete software solution for myocardial perfusion SPECT imaging.

GE Healthcare is licensing SyncTool software as part of an Emory Cardiac Toolbox (ECTb) upgrade on all Xeleris 2 workstations. This software helps to predict which heart failure patients will benefit from cardiac resynchronization therapy (CRT).

Emory University announced it is exclusively licensing Emory Reconstruction Toolbox (ERTb) to Syntermed. The company will market ERTb software as ReconTools.

For more information: www.syntermed.com

Related Content

Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
The Siemens Biograph Vision PET-CT system was released in mid-2018.

The Siemens Biograph Vision PET-CT system was released in mid-2018.

Feature | Nuclear Imaging | September 07, 2018 | By Dave Fornell
Nuclear imaging technology for both single photon emission computed tomography (SPECT) and positron emission tomography...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...
Brain Study of 62,454 Scans Identifies Drives of Brain Aging
News | SPECT Imaging | August 27, 2018
In the largest known brain imaging study, scientists from five institutions evaluated 62,454 brain single photon...
Abnormal Protein Concentrations Found in Brains of Military Personnel With Suspected CTE

Researchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encephalopathy in living patients. In this image, warmer colors indicate a higher concentration of the tracer, which binds to abnormal proteins in the brain. Credit UCLA Health.

News | PET Imaging | August 24, 2018
August 24, 2018 — In a small study of
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
Novel PET Imaging Method Could Track and Guide Type 1 Diabetes Therapy
News | PET Imaging | August 03, 2018
Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The...
Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...